Eloquest Healthcare, Inc.

Eloquest Healthcare, Inc. is a healthcare company focused on enhancing patient care through innovative and cost-effective products and services. As a subsidiary of Ferndale Pharma Group, Inc., which has over 125 years of experience in the healthcare sector, Eloquest aims to reduce hospital-acquired infections, vascular access complications, and skin injuries. The company is dedicated to providing compassionate care solutions that improve patient satisfaction and lower overall care costs. Eloquest Healthcare offers a range of clinically backed products, including Mastisol Liquid Adhesive, Detachol Adhesive Remover, SecurAcath securement devices, and LMX4 Topical Anesthetic Cream. These solutions help hospitals save money, minimize infection risks, and ensure secure attachment of medical devices. The company also supports healthcare providers with educational resources and knowledgeable representatives to enhance clinical outcomes. Manufacturing takes place in the United States at a facility in Michigan, ensuring high quality and careful monitoring of production. Eloquest Healthcare has been recognized as a Great Place to Work for seven consecutive years, highlighting its commitment to a positive workplace culture. Its primary customers include hospitals, healthcare practitioners, and acute care facilities.

• Employees 40
• Founded 2008
• Annual Revenue $35736000